Table 1 Clinical profiles of previous cases of cerebral infarction associated with adenomyosis
Case | Age | Occurrence during menstruation | CA125 (U/mL) | CA19-9 (U/mL) | D-dimer (µg/mL) | Hb (g/dL) | Major cerebral artery | Treatment for CI | Treatment for denomyosis | Recurrence of CI |
|---|---|---|---|---|---|---|---|---|---|---|
1 [1] | 45 | - | 159 | - | 1.1 | 8.4 | Normal | Heparin, antiplatelet therapy | GnRH agonist | - |
2 [1] | 44 | - | - | - | - | 7 | Normal | Heparin, warfarin | GnRH agonist | - |
3 [1] | 50 | + | 42.6 | - | 0.57 | 6.9 | Normal | Aspirin | GnRH agonist | - |
4 [1] | 42 | + | 1750 | - | 6 | 8.6 | Normal | Antiplatelet therapy | GnRH agonist | + |
Heparin, warfarin | GnRH agonist | - | ||||||||
5 [6] | 59 | - | 334.8 | - | 7 | - | - | Antithrombotic therapy | - | - |
6 [7] | 48 | - | 901 | 1791 | 1.9 | 8.5 | Occlusion of the left M1 of MCA | Heparin, warfarin | Hysterectomy | - |
7 [8] | 49 | - | 379 | 69.2 | 3.99 | 9.9 | Normal | Anticoagulant | Hysterectomy | - |
8 [2] | 44 | + | 2115 | 1824 | 17 | 10.3 | Severe stenosis in the right M2of MCA | Heparin, rivaroxaban | GnRH agonist | + |
Hysterectomy | - | |||||||||
9 [3] | 42 | - | 395 | - | 1.4 | - | Occlusion of the left M2 of MCA | Warfarin | - | - |
10 [3] | 50 | - | 143 | - | 3.7 | - | After occlusion of the left M1 of MCA, partial reperfusion of MCA | Rivaroxaban | - | - |
11 [4] | 34 | + | 937.1 | 462.5 | 1.05 | 13.4 | Normal | - | - | - |
12 [4] | 37 | + | 735.7 | 43.2 | 12.04 | 10.8 | Normal | - | - | - |
13 [4] | 46 | + | 546.5 | 1076.6 | 2.34 | 12.1 | Stenosis of the right PCA | - | Hysterectomy | - |
14 [5] | 34 | + | 937.7 | - | 27.4 | 11.2 | Severe stenosis in the right M1 of MCA | Heparin, antiplatelet therapy | - | - |
15 | 48 | + | 3536.2 | 892.1 | 79.3 | 8.2 | Occlusion of the right M1 of MCA | Heparin, edoxaban Endovascular thrombectomy | Hysterectomy | - |